News

QV Bioelectronics has been selected to present at LSI Europe '26, one of medtech's leading showcase events, in Barcelona this September. CEO Carl Daintree will […]

Yesterday, Archie Goodburn appeared on BBC Breakfast calling for a national brain cancer lead and better access to international clinical trials for UK patients. His […]

QV Bioelectronics has been spotlighted in the National Institute for Health and Care Research (NIHR) 2025/26 Annual Report, recognised in the Investment chapter for the […]

We’re excited to welcome Robert to QV Bioelectronics as our new Electronic Systems Engineer! Robert brings deep expertise in mixed-signal electronics, high-density PCB design and […]

Last week on World Brain Tumour Day, QV Bioelectronics reached an important milestone in the development of GRACE, the world's first fully implantable Tumour Treating […]

We’re excited to welcome Eduard Fedorov to QV Bioelectronics!Eduard is a seasoned physicist and technology leader, with over 15 years of interdisciplinary experience spanning advanced […]

QV Bioelectronics was pleased to attend LSI USA 2026 in Dana Point, California, one of the leading global gatherings for emerging medtech companies, investors, and […]

QV Bioelectronics is pleased to announce a leadership transition as the company enters its next phase of growth and clinical development. Carl Daintree has assumed […]

QV Bioelectronics has secured £4.5m in investment and grant funding to support the next phase of development of GRACE, its world-first fully implantable electric field […]

Press Release The project will adapt QV Bioelectronics’ existing electric field therapy (EFT) technology to develop the world’s first fully implantable EFT device to treat […]

Collaboration delivered vital insights to advance revolutionary treatment modality - GRACE ALaSCA platform able to decipher experimental data from complex molecular pathways and simulate ‘what-if’ […]